IL122811A - Process for the optical purification of enantiomerically enriched benzimidazole derivatives - Google Patents

Process for the optical purification of enantiomerically enriched benzimidazole derivatives

Info

Publication number
IL122811A
IL122811A IL12281196A IL12281196A IL122811A IL 122811 A IL122811 A IL 122811A IL 12281196 A IL12281196 A IL 12281196A IL 12281196 A IL12281196 A IL 12281196A IL 122811 A IL122811 A IL 122811A
Authority
IL
Israel
Prior art keywords
enantiomerically enriched
benzimidazole derivatives
optical purification
enriched benzimidazole
purification
Prior art date
Application number
IL12281196A
Other languages
English (en)
Other versions
IL122811A0 (en
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20397468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL122811(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL122811A0 publication Critical patent/IL122811A0/xx
Publication of IL122811A publication Critical patent/IL122811A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12281196A 1995-07-03 1996-06-26 Process for the optical purification of enantiomerically enriched benzimidazole derivatives IL122811A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500817 1995-07-03
PCT/SE1996/000841 WO1997002261A1 (en) 1995-07-03 1996-06-26 A process for the optical purification of enantiomerically enriched benzimidazole derivatives

Publications (2)

Publication Number Publication Date
IL122811A0 IL122811A0 (en) 1998-08-16
IL122811A true IL122811A (en) 2000-11-21

Family

ID=20397468

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12281196A IL122811A (en) 1995-07-03 1996-06-26 Process for the optical purification of enantiomerically enriched benzimidazole derivatives

Country Status (36)

Country Link
US (1) US5929244A (da)
EP (2) EP0836601B1 (da)
JP (1) JP4195507B2 (da)
KR (1) KR100451078B1 (da)
CN (1) CN1098261C (da)
AT (1) ATE418549T1 (da)
AU (1) AU698638B2 (da)
BR (1) BR9609450A (da)
CA (1) CA2226184C (da)
CZ (1) CZ295430B6 (da)
DE (1) DE69637788D1 (da)
DK (1) DK0836601T3 (da)
DZ (1) DZ2057A1 (da)
EE (1) EE03444B1 (da)
ES (1) ES2318850T3 (da)
HR (1) HRP960232A2 (da)
HU (1) HUP9901717A3 (da)
IL (1) IL122811A (da)
IS (1) IS2666B (da)
MA (1) MA23921A1 (da)
MY (1) MY114018A (da)
NO (1) NO313008B1 (da)
NZ (1) NZ311842A (da)
PL (1) PL186702B1 (da)
PT (1) PT836601E (da)
RS (1) RS49826B (da)
RU (1) RU2144031C1 (da)
SA (1) SA96170103B1 (da)
SI (1) SI0836601T1 (da)
SK (1) SK284780B6 (da)
TN (1) TNSN96090A1 (da)
TR (1) TR199701754T1 (da)
TW (1) TW444010B (da)
UA (1) UA49838C2 (da)
WO (1) WO1997002261A1 (da)
ZA (1) ZA965205B (da)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
EP0983263A1 (en) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
JP2002501897A (ja) * 1998-01-30 2002-01-22 セプラコール， インク． Ｒ−ランソプラゾール組成物及び方法
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI275587B (en) 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
DE60020967T2 (de) 1999-06-30 2006-05-04 Takeda Pharmaceutical Co. Ltd. Kristalle von lansoprazole
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
CA2409044C (en) 2000-05-15 2013-02-19 Takeda Chemical Industries, Ltd. Improved recrystallization processes for obtaining anhydrous optically active lansoprazole
AU2001276721A1 (en) 2000-08-04 2002-02-18 Takeda Chemical Industries Ltd. Salts of benzimidazole compound and use thereof
KR20100002278A (ko) 2000-12-01 2010-01-06 다케다 야쿠힌 고교 가부시키가이샤 (ｒ)- 또는 (ｓ)-란소프라졸의 결정
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0104295D0 (sv) * 2001-12-18 2001-12-18 Astrazeneca Ab New process
WO2003063840A2 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
US8697094B2 (en) 2002-10-16 2014-04-15 Takeda Pharmaceutical Company Limited Stable solid preparations
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
EP1575941B1 (en) 2002-12-06 2012-04-11 Nycomed GmbH Process for preparing (S)-pantoprazole
DK1578742T3 (da) 2002-12-06 2013-01-21 Nycomed Gmbh Fremgangsmåde til fremstilling af optisk rene aktive forbindelser
TWI367759B (en) * 2003-02-20 2012-07-11 Santarus Inc A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
US20060247277A1 (en) * 2003-02-28 2006-11-02 Yatendra Kumar Polymorphs of s-omeprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2004257864A1 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
FR2863609A1 (fr) * 2003-12-15 2005-06-17 Isochem Sa Procede d'enrichissement enantiomerique d'un melange d'enantiomeres d'alpha-aminoacides
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
FR2876101B1 (fr) * 2004-10-05 2007-03-02 Sidem Pharma Sa Sa Procede de preparation enantioselective de derives de sulfoxydes
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
FR2909380B1 (fr) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
BRPI0813191B1 (pt) * 2007-06-15 2021-09-08 Emcure Pharmaceuticals Limited Processo de sulfoxidação de compostos biologicamente ativos
CN101323609B (zh) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
LT2262790T (lt) 2008-03-10 2017-08-25 Takeda Pharmaceutical Company Limited Benzimidazolo junginio kristalas
US8354541B2 (en) 2008-11-18 2013-01-15 Hetero Research Foundation Optical purification of esomeprazole
KR101001646B1 (ko) * 2008-12-12 2010-12-17 한미약품 주식회사 (ｒ)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
EP2499125B1 (en) 2009-11-12 2016-01-27 Hetero Research Foundation Process for the resolution of omeprazole
EP2528912A1 (en) 2010-01-29 2012-12-05 Ranbaxy Laboratories Limited Process for the preparation of crystalline forms of dexlansoprazole
PL3176164T3 (pl) * 2014-07-30 2020-05-18 Aetas Pharma Co. Ltd. Izomer optyczny pochodnej 1-tlenku 1,4-benzotiazepiny oraz farmaceutyczna kompozycja wytworzona z jego użyciem
ES2615637T3 (es) * 2015-03-06 2017-06-07 F.I.S.- Fabbrica Italiana Sintetici S.P.A. Procedimiento mejorado para la purificación óptica del esomeprazol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
EP0434999B1 (en) * 1989-11-29 1994-08-17 Toa Eiyo Ltd. Cycloheptenopyridine derivatives, process for preparation thereof and antiulcer agents containing the same
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds

Also Published As

Publication number Publication date
NZ311842A (en) 1998-12-23
KR19990028631A (ko) 1999-04-15
EP0836601B1 (en) 2008-12-24
EP1498416A1 (en) 2005-01-19
DZ2057A1 (fr) 2002-10-20
CZ295430B6 (cs) 2005-08-17
BR9609450A (pt) 1999-03-02
HRP960232A2 (en) 1998-02-28
TNSN96090A1 (fr) 2005-03-15
AU6324096A (en) 1997-02-05
ATE418549T1 (de) 2009-01-15
TW444010B (en) 2001-07-01
IS2666B (is) 2010-08-15
HK1010193A1 (en) 1999-06-17
CZ421197A3 (cs) 1998-06-17
ES2318850T3 (es) 2009-05-01
JPH11508590A (ja) 1999-07-27
CA2226184A1 (en) 1997-01-23
SK284780B6 (sk) 2005-11-03
UA49838C2 (uk) 2002-10-15
EE9700368A (et) 1998-06-15
HUP9901717A2 (hu) 2000-04-28
EP0836601A1 (en) 1998-04-22
MY114018A (en) 2002-07-31
IS4638A (is) 1997-12-22
JP4195507B2 (ja) 2008-12-10
AU698638B2 (en) 1998-11-05
SI0836601T1 (sl) 2009-04-30
RU2144031C1 (ru) 2000-01-10
SA96170103B1 (ar) 2006-07-30
CN1098261C (zh) 2003-01-08
RS49826B (sr) 2008-08-07
PT836601E (pt) 2009-02-17
KR100451078B1 (ko) 2004-11-16
DE69637788D1 (de) 2009-02-05
CA2226184C (en) 2008-08-05
US5929244A (en) 1999-07-27
WO1997002261A1 (en) 1997-01-23
MX9800160A (es) 1998-03-31
HUP9901717A3 (en) 2002-03-28
CN1193971A (zh) 1998-09-23
NO313008B1 (no) 2002-07-29
DK0836601T3 (da) 2009-03-16
MA23921A1 (fr) 1996-12-31
PL186702B1 (pl) 2004-02-27
NO976030L (no) 1998-02-09
EE03444B1 (et) 2001-06-15
NO976030D0 (no) 1997-12-22
TR199701754T1 (xx) 1998-04-21
IL122811A0 (en) 1998-08-16
YU37696A (sh) 1999-03-04
PL324394A1 (en) 1998-05-25
ZA965205B (en) 1997-01-03
SK179397A3 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
NZ311842A (en) A process for the optical purification of enantiomerically enriched benzimidazole derivatives
IL122339A (en) Optically active (s)-(+) enantiomers of 2-imidiazoline-5-thione derivatives
FI960278A0 (fi) Anataasititaanidioksidin valmistusmenetelmä
EP0744431A3 (en) Process for the production of aromatic polyamides
HUP9900110A3 (en) Novel process for the synthesis of omeprazole
ITMI951445A0 (it) Procedimento per la produzione di carbammati aromatici
NO970212L (no) Fremgangsmåte for fremstilling av enantiomerene av O-demetyltramadol
DE69423179D1 (de) Prozess zur Herstellung von optisch aktiven 2-Amino-1-phenylethanol Derivaten
IL124645A0 (en) Process for the production of 1, 2-bis (acyloxylates)
GR3032600T3 (en) Process for the production of imidazo-benzodiazepine derivatives
GB2294256B (en) Apparatus for the production of oxygen
EE03393B1 (et) Protsess enantiomeerselt puhta asetidiin-2-karboksüülhappe saamiseks
ZA963132B (en) Process for the preparation of pure enantiomers of 1-2-pyridyl)-2-cyclo-hexylethylamine.
NO990450D0 (no) Behandling av sinnslidelser
DE69610747D1 (de) Verfahren zur Herstellung von hochreinem 2,4'-Dihydroxydiphenylsulfon
NO974524D0 (no) Fremgangsmåte for rensing av glykoproteiner som erytropoietin
NO973835L (no) Fremgangsmåte for fremstilling av lorakarbefmonohydrat
FR2721312B1 (fr) Procédé de fabrication d'halogénoalcanols.
HK1024691A (en) Process for the production of enantiomerically enriched $i(n)-acylazetidine-2-carboxylic acids
SE9502381D0 (sv) Process for the production of enantiomerically-pure azetidine-2-carboxylic acid
EP0490407A3 (en) Process for the enzymatic separation of the optical isomers of tosyloxy-alkanols
EP0461531A3 (en) Process for the purification of 2-chloro-5-nitrobenzaldehyde or their acetals

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees